FDG-PET in a myocardial tuberculoma

Age and Ageing

Volumn 44, Issue 1, 2015, Pages 173-174

  Braquet, Pierre ^a   Baptista, Gregory ^a   Ilonca, Diana Alina ^a   Roubille, François ^a   Le Moing, Vincent ^a   Jeandel, Claude ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TUBERCULOSTATIC AGENT; RADIOPHARMACEUTICAL AGENT;

AGED; ATRIOVENTRICULAR BLOCK; BODY WEIGHT LOSS; BRADYCARDIA; CASE REPORT; CLINICAL ARTICLE; DISEASE COURSE; FAINTNESS; FATIGUE; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; MYOCARDIAL DISEASE; MYOCARDIAL TUBERCULOMA; POSITRON EMISSION TOMOGRAPHY; SEIZURE; SHORT SURVEY; TREATMENT DURATION; TUBERCULOMA; VERY ELDERLY; CARDIOMYOPATHIES; DIAGNOSTIC USE; HEART; MICROBIOLOGY; PREDICTIVE VALUE; SCINTISCANNING; TIME; TREATMENT OUTCOME; TUBERCULOSIS, CARDIOVASCULAR;

AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CARDIOMYOPATHIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOMA; TUBERCULOSIS, CARDIOVASCULAR;

EID: 84938532860     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/AGEING/AFU147     Document Type: Short Survey

References (3)

1. Rose AG. Cardiac tuberculosis. A study of 19 patients. Arch Pathol Lab Med 1987; 111: 422-6.
2. Heysell SK, Thomas TA, Sifri CD, Rehm PK, Houpt ER. 18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series. BMC Pulm Med 2013; 13: 14.
3. Martinez V, Castilla-Lievre MA, Guillet-Caruba C et al. (18) F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response. Int J Tuberc Lung Dis 2012; 16: 1180-5.